The role of Substance P in the defense line of the respiratory tract and neurological manifestations post COVID-19 infection

Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction

(2022) Tommaso Schirinzi et al.   BRAIN BEHAVIOR AND IMMUNITY

Neuropeptides, New Ligands of SARS-CoV-2 Nucleoprotein, a Potential Link between Replication, Inflammation and Neurotransmission

(2022) Julien Henri et al.   MOLECULES

Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)

(2021) Samuel Egieyeh et al.   PLoS One

Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification

(2021) César Fernández-de-las-Peñas et al.   International Journal of Environmental Research and Public Health

Clinical and Pathophysiologic Spectrum of Neuro-COVID

(2021) Josef Finsterer et al.   MOLECULAR NEUROBIOLOGY

Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment

(2021) Riffat Mehboob   BIOMEDICINE & PHARMACOTHERAPY

Neuro-COVID-19: an insidious virus in action

(2021) Jolanta Bratosiewicz-Wąsik   Neurologia i Neurochirurgia Polska

Substance P/ Neurokinin-1 Receptor, Trigeminal Ganglion, Latency, and Coronavirus Infection-Is There Any Link?

(2021) Riffat Mehboob et al.   Frontiers in Medicine

Serotonin and substance P: Synergy or competition in the control of breathing

(2020) Małgorzata Szereda-Przestaszewska et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning

(2020) Yehuda Shoenfeld   AUTOIMMUNITY REVIEWS

COVID‐19 and Headache: A Primer for Trainees

(2020) Sarah M. Bobker et al.   HEADACHE

Neurological Involvement in COVID-19 and Potential Mechanisms: A Review

(2020) Ghazal Aghagoli et al.   Neurocritical Care

Long covid could be four different syndromes, review suggests

(2020) Elisabeth Mahase   BMJ-British Medical Journal

The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19

(2020) Alessandro Bellis et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Neuropathological explanation of minimal COVID-19 infection rate in newborns, infants and children – a mystery so far. New insight into the role of Substance P

(2020) Riffat Mehboob et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Neurological issues in children with COVID-19

(2020) Jieru E. Lin et al.   NEUROSCIENCE LETTERS

Does COVID‐19 contribute to development of neurological disease?

(2020) Arehally M. Mahalakshmi et al.   Immunity Inflammation and Disease

Potential association of mast cells with coronavirus disease 2019

(2020) Theoharis C. Theoharides   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

The Neurokinin-1 Receptor Antagonist Orvepitant is a Novel Antitussive Therapy for Chronic Refractory Cough

(2019) Jaclyn Smith et al.   CHEST

Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development

(2018) Fiona M. Bright et al.   BRAIN RESEARCH BULLETIN

Substance P represents a novel first-line defense mechanism in the nose

(2018) Olivia Larsson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The potential role of substance P in brainstem homeostatic control in the pathogenesis of sudden infant death syndrome (SIDS)

(2018) Fiona M. Bright et al.   NEUROPEPTIDES

Neuropeptides and breathing in health and disease

(2018) Katarzyna Kaczyńska et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex

(2017) Fiona M. Bright et al.   PLoS One

Towards Better Understanding of the Pathogenesis of Neuronal Respiratory Network in Sudden Perinatal Death

(2017) Riffat Mehboob et al.   Frontiers in Neurology

Substance P/Neurokinin 1 and Trigeminal System: A Possible Link to the Pathogenesis in Sudden Perinatal Deaths

(2017) Riffat Mehboob   Frontiers in Neurology

Immunohistochemical Analysis of Brainstem Lesions in the Autopsy Cases with Severe Motor and Intellectual Disabilities Showing Sudden Unexplained Death

(2016) Masaharu Hayashi et al.   Frontiers in Neurology

Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis

(2015) Prema Robinson et al.   Biomed Research International

Involvement of substance P and the NK-1 receptor in cancer progression

(2013) Miguel Muñoz et al.   PEPTIDES

Developmental alterations of the spinal trigeminal nucleus disclosed by substance P immunohistochemistry in fetal and infant sudden unexplained deaths

(2011) Anna M. Lavezzi et al.   NEUROPATHOLOGY

Functional Studies with Substance P Analogues: Effects of N-Terminal, C-Terminal, and C-Terminus-Extended Analogues of Substance P on Nicotine-Induced Secretion and Desensitization in Cultured Bovine Adrenal Chromaffin Cells

(2010) Nam Sang Cheung et al.   JOURNAL OF NEUROCHEMISTRY